Overactive Bladder Clinical Trials

Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients

Therapy of the Overactive Bladder Syndrome (TOBS)

A Study of the Pharmacokinetics and Pharmacodynamics of MK4618 in Women With Overactive Bladder (MK-4618-004)

Trospium Chloride XR in Obese Female Patients With Overactive Bladder

Evaluation of Autonomic System Before and After Anticholinergic Treatment in Women With Overactive Bladder

A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo Administered as Oral Daily Dose for Three Months in Patients Suffering From Overactive Bladder

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Comparison of Motor and Sensory Response With Interstim Stimulation

Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents

A Prospective, Multi-center, Placebo-controlled, Randomized, Double-blind, Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo Administered as Oral Daily Dose for Three Months in Patients Suffering

Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction

Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder

The Effect of Position on Urge Sensation in Volunteers and in Patients With Overactive Bladder Syndrome

Efficacy Study of Adalimumab to Treat Interstitial Cystitis

A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Alone and in Combination for the Treatment of Overactive Bladder (Symphony)

Evaluating the Treatment of Overactive Bladder Symptoms in Women Post Pubovaginal Sling Procedure

A Study of the Efficacy and Safety of MK-4618 in Patients With Overactive Bladder (OAB) (MK-4618-008 AM1 EXT)

Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)

A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine

Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder

Combined Behavioral and Drug Treatment of Overactive Bladder in Men (COBALT)

Safety and Effectiveness of a Non-invasive Neuromodulation Device on Urgency Urinary Incontinence in Overactive Bladder (Beacon)

Effects and Safety of Liposome Encapsulated Botulinum Toxin A for Overactive Bladder Syndrome

Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder

Comparative Urine Proteomic Studies of Overactive Bladder in Humans

A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.

Grouptraining for Overactive Bladder in Adults

Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder (REMOTE)

Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease (URGE-PD)

Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder

Overactive Bladder News

Repeated Toxin Injections Safe and Effective for Refractory Overactive Bladder

Overactive Bladder Linked to Metabolic Syndrome in Women

Approval Sought for New Overactive Bladder Drug

Latest CME Article

Renal & Urology News includes a CME article in every print issue, which will also be available online.

View the latest installment:

Renal Cell Carcinoma Tumor

An Update on Robotic-Assisted Partial Nephrectomy

Cartoons
 Subscribe to the RSS for this page  [view all our RSS feeds here]
Popular Topics
Acute Kidney Injury Anemia Bladder Cancer BPH Cardiovascular Disease Chronic Kidney Disease CKD Diabetes Epidemiology Erectile Dysfunction Hemodialysis Hyperphosphatemia Hypertension Infection Kidney Cancer Kidney Stones Nutrition Overactive Bladder Peritoneal Dialysis Prostate Cancer PSA Reproductive Medicine Transplantation Urinary Incontinence UTI

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions